These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Treatment of hypereosinophilic syndromes of myeloproliferative expression with the combination of hydroxyurea and interferon alpha. Apropos of 7 cases]. Coutant G; Blétry O; Prin L; Hauteville D; de Puyfontaine O; Abgrall JF; Godeau P Ann Med Interne (Paris); 1993; 144(4):243-50. PubMed ID: 8368716 [TBL] [Abstract][Full Text] [Related]
3. World Health Organization-defined eosinophilic disorders: 2014 update on diagnosis, risk stratification, and management. Gotlib J Am J Hematol; 2014 Mar; 89(3):325-37. PubMed ID: 24577808 [TBL] [Abstract][Full Text] [Related]
4. World Health Organization-defined eosinophilic disorders: 2015 update on diagnosis, risk stratification, and management. Gotlib J Am J Hematol; 2015 Nov; 90(11):1077-89. PubMed ID: 26486351 [TBL] [Abstract][Full Text] [Related]
5. World Health Organization-defined eosinophilic disorders: 2022 update on diagnosis, risk stratification, and management. Shomali W; Gotlib J Am J Hematol; 2022 Jan; 97(1):129-148. PubMed ID: 34533850 [TBL] [Abstract][Full Text] [Related]
6. Favorable response to high-dose interferon-alpha in idiopathic hypereosinophilic syndrome with restrictive cardiomyopathy--case report and literature review. Baratta L; Afeltra A; Delfino M; De Castro S; Giorgino F; Rossi-Fanelli F Angiology; 2002; 53(4):465-70. PubMed ID: 12143954 [TBL] [Abstract][Full Text] [Related]
7. Complete haematological and cytogenetic response to interferon alpha-2a of a myeloproliferative disorder with eosinophilia associated with a unique t(4;7) aberration. Schöffski P; Ganser A; Pascheberg U; Büsche G; Gaede B; Hertenstein B Ann Hematol; 2000 Feb; 79(2):95-8. PubMed ID: 10741923 [TBL] [Abstract][Full Text] [Related]
8. [Hypereosinophilic syndrome in a myeloproliferative variety. Success after 18 month treatment with interferon alpha]. Dine G; Najman A; Brahimi S; Culioli B; Abid A; Dupoirieux J Presse Med; 1992 Nov; 21(37):1776. PubMed ID: 1488427 [No Abstract] [Full Text] [Related]
9. Hypereosinophilic syndrome and plasmocytoma. Report of a case and review of the literature. Franchi F; De Rosa F; Seminara P; Calvieri S; Carfagna GF; Bosman C Acta Haematol; 1984; 72(1):14-20. PubMed ID: 6433626 [TBL] [Abstract][Full Text] [Related]
10. [Interferon-alpha therapy in the myeloproliferative variants of hypereosinophilic syndrome]. Kobayashi M; Katayama T; Ochiai S; Yoshida M; Kaito K; Masuoka H; Shimada T; Nishiwaki K; Sakai O Rinsho Ketsueki; 1993 Mar; 34(3):367-72. PubMed ID: 8479090 [TBL] [Abstract][Full Text] [Related]